Takeda Pharmaceutical Company
Search results
- Open1,605.00High1,609.00Low1,585.00
- Mkt Cap2851.03BP/E (TTM)169.51Div & Yield74.00 & 4.63%
- Prev. Close1,599.0052 Wk. Low1,426.0052 Wk. High2,270.00
Related stocks
Open | 1,605.00 |
High | 1,609.00 |
Low | 1,585.00 |
Mkt Cap | 2851.03B |
P/E (TTM) | 169.51 |
Div & Yield | 74.00 & 4.63% |
Prev. Close | 1,599.00 |
52 Wk. Low | 1,426.00 |
52 Wk. High | 2,270.00 |
Related stocks
Company
Astellas Pharma is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of and . Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 414.6B | 17.00% ▲ |
Net Income | -33.28B | - |
Diluted EPS | -18.55 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | ¥9.88 | - |
Q1 2024 | ¥4.62 | -¥18.55 |
Q4 2023 | ¥15.30 | ¥10.40 |
S&P 500^GSPC | 5,460.48-22.39 (-0.41%) |
Dow 30^DJI | 39,118.86-45.20 (-0.12%) |
Nasdaq^IXIC | 17,732.60-126.08 (-0.71%) |
12.35-34.83% | |
123.80-4.64% | |
32.75-10.84% |